News SOCL CAPI

Equities

DNAC

KYG8253W1096

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
2.81 ^USD	+7.66%		+27.73%	-71.44%

2022	Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
2022	ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
SOCL CAPI : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	22-07-15	PU
ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading	22-07-12	MT
Social Capital Suvretta III : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	22-07-12	PU
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III	22-07-12	AQ
Social Capital Suvretta Holdings Corp. III(NasdaqCM:DNAC) dropped from NASDAQ Composite Index	22-07-12	CI
Social Capital Suvretta III : Announces Reconvened Extraordinary General Meeting of Shareholders - Form 8-K	22-07-11	PU
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
ProKidney LLC completed the acquisition of Social Capital Suvretta Holdings Corp. III from SCS Sponsor III LLC, Millennium Management LLC, Adage Capital Management, L.P. and others in a reverse merger transaction.	22-07-10	CI
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders	22-07-08	BU
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Other Events (form 8-K)	22-07-06	AQ
Social Capital Suvretta III : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K/A	22-06-10	PU
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III Other Events, Financial Statements and Exhibits (form 8-K/A)	22-06-10	AQ
Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Update	22-06-07	AQ
ProKidney to present at upcoming investor conferences	22-05-20	AQ
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-16	AQ
Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-04-28	AQ
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-04-22	AQ
Social Capital Suvretta Holdings Corp. III Issues an Unsecured Promissory Note	22-04-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SOCL CAPI

Equities

DNAC

KYG8253W1096

Summary

Filters